Tech Company Financing Transactions
Transparency Life Sciences Funding Round
Transparency Life Sciences, based in New York, scored $5 million from New Ventures and private investors.
Transaction Overview
Company Name
Announced On
2/16/2018
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
New Ventures (Lead Investor) (Richard Warburg)
Proceeds Purpose
TLS will use the new financing to expand the company's technology platform and clinical operations infrastructure, and drive commercialization of its integrated digital approach to clinical drug development.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
225 West 60th St. 15d
New York, NY 10023
USA
New York, NY 10023
USA
Phone
Website
Email Address
Overview
Transparency Life Sciences, the first all-digital drug development services company, harnesses crowdsourcing and mobile health technology to advance biopharma candidates through clinical trials with unprecedented patient relevance and efficiency.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lawrence Steinman
Chief Executive Officer
Tomasz Sablinski
Chief Financial Officer
Stuart Barlow
Chief Operating Officer
Marc Foster
VP - Bus. Development
Donna Thornton
VP - Operations
Susan Wong
Browse more venture capital transactions:
Prev: 2/16/2018: Ocugen venture capital transaction
Next: 2/16/2018: Miso Robotics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs